A study evaluating effect of Idelalisib and duration of response after toxicity related discontinuation of Idelalisib.
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Idelalisib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 20 Dec 2017 New trial record
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology